Involvement of TLR4-JNK/NF-κB signaling pathway in RAW264.7 cell activation of Protaetia brevitarsis seulensis larvae extracts

Medicine and Dentistry

• Signal Transduction 100%
• Phosphotransferase 100%
• Immunoglobulin Enhancer Binding Protein 100%
• Amino Terminal Sequence 100%
• Cell Activation 100%
• Toll Like Receptor 4 100%
• Macrophage 40%
• Mitogen-Activated Protein Kinase 40%
• Group Therapy 40%
• Therapeutic Procedure 20%
• Immunocompetent Cell 20%
• Cytokine 20%
• Immune System 20%
• Tumor Necrosis Factor 20%
• Inducible Nitric Oxide Synthase 20%
• Nitric Oxide 20%
• Phosphotransferase Inhibitor 20%
• Cyclooxygenase 2 20%
• Prostaglandin E2 20%
• Innate Immunity 20%
• I Kappa B 20%
• Immunoglobulin 20%

Immunology and Microbiology

• TLR4 100%
• Signal Transduction 100%
• Extract 100%
• Amino Terminal Sequence 100%
• Cell Activation 100%
• Immunoglobulin Enhancer Binding Protein 100%
• Macrophage 33%
• Human 33%
• Mitogen 33%
• Innate Immune System 16%
• Immunocompetent Cell 16%
• Tumor Necrosis Factor Alpha 16%
• Proinflammatory Cytokine 16%
• Reduction (Chemistry) 16%
• Intravenous Immunoglobulin 16%
• Prostaglandin E2 16%
• Immune System 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Toll Like Receptor 4 100%
• Phosphotransferase 100%
• Immunoglobulin Enhancer Binding Protein 100%
• Mitogen Activated Protein Kinase 40%
• Human 40%
• Cytokine 20%
• Inducible Nitric Oxide Synthase 20%
• Nitric Oxide 20%
• Tumor Necrosis Factor 20%
• Prostaglandin E2 20%
• Immunoglobulin 20%
• Cyclooxygenase 2 20%
• Phosphotransferase Inhibitor 20%